Resmed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2026. “We began fiscal year 2027 with a strong first quarter, driven by continued global demand for our ...
ResMed Inc. reported earnings results for the first quarter ended September 30, 2026. For the first quarter, the company reported sales was USD 1,414.81 million compared to USD 1,335.58 million a year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results